Wells Fargo’s LENZ Therapeutics LENZ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $273K | Buy |
9,326
+1,657
| +22% | +$48.6K | ﹤0.01% | 4193 |
|
|
2025
Q1 | $197K | Buy |
7,669
+165
| +2% | +$4.24K | ﹤0.01% | 4275 |
|
|
2024
Q4 | $217K | Buy |
7,504
+1,608
| +27% | +$46.4K | ﹤0.01% | 4271 |
|
|
2024
Q3 | $140K | Buy |
5,896
+247
| +4% | +$5.86K | ﹤0.01% | 4425 |
|
|
2024
Q2 | $97.7K | Buy |
5,649
+4,290
| +316% | +$74.2K | ﹤0.01% | 4594 |
|
|
2024
Q1 | $30.3K | Buy |
1,359
+54
| +4% | +$1.21K | ﹤0.01% | 5065 |
|
|
2023
Q4 | $23.9K | Buy |
1,305
+244
| +23% | +$4.47K | ﹤0.01% | 5137 |
|
|
2023
Q3 | $18.4K | Sell |
1,061
-916
| -46% | -$15.9K | ﹤0.01% | 5267 |
|
|
2023
Q2 | $36K | Buy |
1,977
+1,498
| +313% | +$27.3K | ﹤0.01% | 5270 |
|
|
2023
Q1 | $8.22K | Hold |
479
| – | – | ﹤0.01% | 5602 |
|
|
2022
Q4 | $11.1K | Sell |
479
-28
| -6% | -$651 | ﹤0.01% | 5183 |
|
|
2022
Q3 | $12K | Buy |
507
+12
| +2% | +$284 | ﹤0.01% | 5295 |
|
|
2022
Q2 | $9K | Sell |
495
-962
| -66% | -$17.5K | ﹤0.01% | 5519 |
|
|
2022
Q1 | $52K | Sell |
1,457
-388
| -21% | -$13.8K | ﹤0.01% | 5310 |
|
|
2021
Q4 | $160K | Buy |
1,845
+1,423
| +337% | +$123K | ﹤0.01% | 5011 |
|
|
2021
Q3 | $48K | Buy |
+422
| New | +$48K | ﹤0.01% | 5334 |
|